-+ 0.00%
-+ 0.00%
-+ 0.00%

Halozyme bylaws allow majority shareholders to remove directors without cause

PUBT·04/24/2026 20:07:15
Listen to the news
Halozyme bylaws allow majority shareholders to remove directors without cause
  • Halozyme Therapeutics amended bylaws on April 22, 2026.
  • Changes allow stockholders holding majority of voting shares to remove directors at any time, with or without cause.
  • Revision bars stockholder action by written consent, requiring actions be taken at annual or special meetings.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Halozyme Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001159036-26-000051), on April 24, 2026, and is solely responsible for the information contained therein.